Population,Intervention,Comparison,Outcome,Measure,Effect,CI Lower,CI Upper,Significant,Number of participants,Number of studies,Certainty of the evidence (GRADE),Reasons for GRADE if not High,Risk of bias,Imprecision,Inconsistency,Indirectness,Publication bias
patients with oral cavity and oropharyngeal cancer,induction chemotherapy plus locoregional treatment (LRT),locoregional treatment,Total Mortality,HR,0.92,0.84,1,FALSE,4051,25,Very low,"Four studies at low risk of bias, 12 are unclear and 9 are at high risk of bias
Studies included patients with other head and neck cancers",TRUE,FALSE,FALSE,TRUE,FALSE
patients with oral cavity and oropharyngeal cancer,induction chemotherapy plus locoregional treatment (LRT),locoregional treatment,Total Mortality,HR,0.8,0.67,0.97,TRUE,968,4,Moderate,Studies included patients with other head and neck cancers,FALSE,FALSE,FALSE,TRUE,FALSE
patients with oral cavity and oropharyngeal cancer,surgery +/- RT + chemotherapy,surgery +/- RT alone,Total Mortality,HR,0.88,0.79,0.99,TRUE,2017,10,Low,"Four studies are at low risk of bias and 6 are at unclear risk of bias
Studies included patients with other head and neck cancers",TRUE,FALSE,FALSE,TRUE,FALSE
patients with oral cavity and oropharyngeal cancer,surgery +/- RT + chemotherapy,surgery +/- RT alone,Total Mortality,HR,0.88,0.74,1.05,FALSE,758,4,Moderate,Studies included patients with other head and neck cancers,FALSE,FALSE,FALSE,TRUE,FALSE
patients with oral cavity and oropharyngeal cancer,concomitant chemoradiotherapy,radiotherapy alone,Total Mortality,HR,0.78,0.73,0.83,TRUE,4734,26,Low,"Nine trials are at low risk of bias, and remaining 17 at unclear risk of bias
Trials include patients with other head and neck cancers",TRUE,FALSE,FALSE,TRUE,FALSE
patients with oral cavity and oropharyngeal cancer,concomitant chemoradiotherapy,radiotherapy alone,Total Mortality,HR,0.87,0.79,0.95,TRUE,2266,9,Moderate,Trials include patients with other head and neck cancers,FALSE,FALSE,FALSE,TRUE,FALSE
